We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.
- Authors
Stevens, R J; Ali, R; Bankhead, C R; Bethel, M A; Cairns, B J; Camisasca, R P; Crowe, F L; Farmer, A J; Harrison, S; Hirst, J A; Home, P; Kahn, S E; McLellan, J H; Perera, R; Plüddemann, A; Ramachandran, A; Roberts, N W; Rose, P W; Schweizer, A; Viberti, G; Holman, R R
- Abstract
Observational studies suggest that metformin may reduce cancer risk by approximately one-third. We examined cancer outcomes and all-cause mortality in published randomised controlled trials (RCTs).
- Publication
Diabetologia, 2012, Vol 55, Issue 10, p2593
- ISSN
1432-0428
- Publication type
Journal Article
- DOI
10.1007/s00125-012-2653-7